Gluten-free proteases EDC recently launched ENZECO Protease 400 WF to support companies seeking alternative proteases for gluten-free claim requirements, presenting a sales opportunity to food manufacturers facing gluten-related labeling and texture challenges.

Strategic leadership New president Brian Murdoch appointed in 2024 along with a senior management advisor, signaling a potential shift in strategic focus and growth initiatives that could open doors for new partnerships, channel development, and enterprise deals.

Product diversification Historical launches of food-grade biocatalysts like ENZECO FICIN 100 and ongoing enzyme applications across food processing, animal feed, brewing, and distilling indicate cross-sell opportunities to existing customers and adjacent markets.

Regional footprint Headquartered in New York City with a manufacturing facility in Scranton, PA, EDC has a U.S. production base that can support regional supply agreements, faster fulfillment, and co-development projects with North American partners.

SMB market positioning With 11-50 employees and revenue in the mid tens of millions, EDC appears positioned to partner with mid-market food and beverage players who need flexible enzyme solutions, custom formulations, and scalable pilot programs.